3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Melanoma
1
Interventions
pembrolizumab
69
Nivolumab
57
Ipilimumab
36
Specimen Handling
32
Magnetic Resonance Spectroscopy
25
Cyclophosphamide
22
Biopsy
18
cemiplimab
14
fludarabine
13
relatlimab
11
binimetinib
11
Opdualag
11
CTLA-4 Antigen
11
trametinib
10
fludarabine phosphate
10
Radiosurgery
10
avelumab
9
lifileucel
8
dabrafenib
8
Radiotherapy
8
atezolizumab
7
aldesleukin
7
Paclitaxel
7
Blood Specimen Collection
7
encorafenib
6
X-Rays
6
Standard of Care
6
Interleukin-2
6
Immunoglobulin G
6
HhAntag691
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Technetium
×
Dermatologic
×
90 days
×
Clear all
NCT07552597
2026-04-27
MagMen-II
Vastra Gotaland Region
Phase 3
Not yet recruiting
254 enrolled